Adaptimmune Therapeutics plc
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2014 | $36.8M | $35.5M | $1.4M | $332.0K |
| FY2015 | $-29.7M | $-34.7M | $5.1M | $7.1M |
| FY2016 | $-48.2M | $-59.7M | $11.5M | $8.8M |
| FY2017 | $-54.3M | $-79.0M | $24.6M | $10.8M |
| FY2018 | $-104.4M | $-108.3M | $3.9M | $16.2M |
| FY2019 | $-112.5M | $-114.1M | $1.6M | $11.1M |
| FY2020 | $-53.6M | $-55.9M | $2.3M | $10.4M |
| FY2021 | $10.7M | $2.2M | $8.6M | $20.6M |
| FY2022 | $-141.8M | $-171.3M | $29.5M | $18.2M |
| FY2023 | $-140.9M | $-145.6M | $4.7M | $11.8M |
| FY2024 | $-73.2M | $-74.1M | $886.0K | $12.1M |